- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06540092
Early Pregnancy Ultrasound Measurements and Prediction of First Trimester Pregnancy Loss.
August 1, 2024 updated by: Hend Mahmoud Abdelghany, Kasr El Aini Hospital
Ultrasound measurements of fetus during first trimester may be an indicator of first trimester pregnancy loss.
Investigators took 4 measurements of the fetus on 2 intervals during first trimester to confirm this hypothesis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Ultrasound examination of gestational sac (GS) diameter, yolk sac (YS) diameter, crown rump length (CRL) diameter, embryonal heart rate (HR) using Samsung Medison SonoAce R3 through transvaginal probes (6.5 MHz) was conducted on 126 pregnant women.
At least 2 scans were done for each participant one between 6-8 weeks and another one by the end of first trimester.
Results then were compared to get the cut off values that can predict pregnancy loss.
Study Type
Observational
Enrollment (Actual)
126
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Old Cairo
-
Cairo, Old Cairo, Egypt, 11562
- kasr Al Aini, Faculty of Medicine, Cairo University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
126 pregnant women between 6- 13 weeks
Description
Inclusion Criteria:
• Healthy pregnant female patient in the reproductive age group; 18 - 40 years old.
- Gestational age: 6 - 13 weeks of gestations.
- Singlton or multifetal pregnancy.
- Any mode of conception included spontaneous, after superovulation with clomiphene citrate or letrozole with, or without, intrauterine insemination (IUI), and in vitro fertilization (IVF) after superovulation with gonadotropins.
Exclusion Criteria:
• Patient with unsure date for the last menstrual period.
- Pregnant women above 13 weeks gestation.
- Patient with symptoms of threatened abortion or ectopic pregnancy at the initial antenatal visit.
- Patient unable to come for follow up.
- Any medical disorders as DM, HTN, …
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The relation between early pregnancy ultrasound measurements (GSD, YSD, CRL, HR), viability, and continuation of pregnancy till 13 weeks of gestation.
Time Frame: 6-7 weeks
|
2 measures of the fetus were obtained and compared to get first trimester pregnancy outcome
|
6-7 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 19, 2024
Primary Completion (Actual)
June 26, 2024
Study Completion (Actual)
July 30, 2024
Study Registration Dates
First Submitted
August 1, 2024
First Submitted That Met QC Criteria
August 1, 2024
First Posted (Actual)
August 6, 2024
Study Record Updates
Last Update Posted (Actual)
August 6, 2024
Last Update Submitted That Met QC Criteria
August 1, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MS-521-2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on First Trimester Abortion
-
Central Hospital, Nancy, FranceCompletedAbortion in First Trimester | Abortion, Second Trimester
-
University of California, San DiegoCompleted
-
Stanford UniversityGynuity Health ProjectsTerminated
-
Medstar Health Research InstituteSociety of Family PlanningCompletedFirst Trimester AbortionUnited States
-
Gynuity Health ProjectsCompletedAbortion, First TrimesterArmenia, Azerbaijan
-
Gynuity Health ProjectsCompletedAbortion, First TrimesterGeorgia
-
Gynuity Health ProjectsCompletedAbortion, First TrimesterArmenia, Azerbaijan, Mexico, Puerto Rico
-
University of Cape TownKarolinska Institutet; University of California, San Francisco; Grand Challenges...Recruiting
-
KK Women's and Children's HospitalRecruitingAbortion in First TrimesterSingapore
-
Washington University School of MedicineCompletedAbortion in First TrimesterUnited States
Clinical Trials on ultrasound
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Cairo UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
Oregon Health and Science UniversityRecruiting
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States
-
Odense University HospitalEnrolling by invitationThoracic Ultrasound | Fibrosing Interstitial Lung DiseasesDenmark
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedShoulder Impingement Syndrome | Shoulder PainTurkey
-
John PelleritoGeneral ElectricActive, not recruiting